Research and Markets: Biotechnology in the US - Healthcare Reform and Agricultural Demands will Drive Growth
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/6xbprh/biotechnology_in) has announced the addition of the "Biotechnology in the US" report to their offering.
Demand for cutting-edge medicines and treatments will result in strong growth for the Biotechnology industry. While it was not entirely immune to the recession, healthcare reform, environmental concerns and the aging population will drive solid revenue growth in the next five years. Furthermore, federal mandates will likely benefit the industry, leading to increases in research and development over the period.
Firms in this industry primarily use living organisms or molecular and cellular techniques to provide chemicals, food and services that meet human needs. The industry excludes companies primarily involved in developing small-molecule pharmaceuticals, performing contract research or manufacturing biological equipment.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
- Monsanto Company
- Amgen Inc.
Key Topics Covered:
ABOUT THIS INDUSTRY
INDUSTRY AT A GLANCE
PRODUCTS & MARKETS
JARGON & GLOSSARY
For more information visit http://www.researchandmarkets.com/research/6xbprh/biotechnology_in
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.